| Literature DB >> 29166607 |
Zhiwei Zhou1, Xuejie Yang1, Jiangping He2, Jing Liu3, Fang Wu1, Shengyong Yu3, Yuting Liu3, Runxia Lin1, He Liu1, Yuanbin Cui4, Chunhua Zhou1, Xiaoshan Wang2, Jian Wu1, Shangtao Cao1, Lin Guo3, Lihui Lin2, Tao Wang3, Xiaozhong Peng5, Boqing Qiang5, Andrew P Hutchins6, Duanqing Pei7, Jiekai Chen8.
Abstract
Polycomb repressive complex 1 (PRC1) plays essential roles in cell-fate determination. Recent studies have found that the composition of mammalian PRC1 is particularly varied and complex; however, little is known about the functional consequences of these variant PRC1 complexes on cell-fate determination. Here, we show that Kdm2b promotes Oct4-induced somatic reprogramming through recruitment of a variant PRC1 complex (PRC1.1) to CpG islands (CGIs). Furthermore, we find that bone morphogenetic protein (BMP) represses Oct4/Kdm2b-induced somatic reprogramming selectively. Mechanistically, BMP-SMAD pathway attenuates PRC1.1 occupation and H2AK119 ubiquitination at genes linked to development, resulting in the expression of mesendodermal factors such as Sox17 and a consequent suppression of somatic reprogramming. These observations reveal that PRC1.1 participates in the establishment of pluripotency and identify BMP4 signaling as a modulator of PRC1.1 function.Entities:
Keywords: BMP signaling; Kdm2b; PRC1; Polycomb repressive complex 1; epigenetic regulation; iPS; pluripotency; reprogramming; variant PRC1
Mesh:
Substances:
Year: 2017 PMID: 29166607 DOI: 10.1016/j.celrep.2017.10.091
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423